Reports by Industry

Pharmaceuticals Market Reports

Pharmaceuticals Market Reports

Global Chronic Lymphocytic Leukemia Therapeutics Market Size, Trends & Analysis - Forecasts to 2029 By Drug Type (Chemotherapy Drugs, Targeted Therapy, and Others), By Route of Administration (Oral, Intravenous, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global chronic lymphocytic leukemia (CLL) therapeutics market is estimated to exhibit a CAGR of 7.2% from 2024 to 2029. Read More »
May 8 : 2024

Global Pharmaceutical Analytical Testing Outsourcing Market Size, Trends & Analysis - Forecasts to 2029 By Service (Bioanalytical Testing, Method Development & Validation, Stability Testing, and Others), By End-use (Pharmaceutical Companies, Biopharmaceutical Companies, and Contract Research Organizations), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global pharmaceutical analytical testing outsourcing market is estimated to exhibit a CAGR of 8.6% from 2024 to 2029. Read More »
May 7 : 2024

Global Premenstrual Syndrome Treatment Market Size, Trends & Analysis - Forecasts to 2029 By Drug Type (Analgesics, Antidepressants, Oral Contraceptives & Ovarian Suppression Agents, and Others), By Type (Prescription and OTC), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global premenstrual syndrome (PMS) treatment market is estimated to exhibit a CAGR of 3.6% from 2024 to 2029. Read More »
May 6 : 2024

Global Myocardial Infarction Market Size, Trends & Analysis - Forecasts to 2029 By Drug Class (Antiplatelet Agents, Glycoprotein IIb/IIIa Inhibitors, Antithrombotic Agents, Beta-adrenergic Blockers, Vasodilators, Angiotensin-converting Enzyme (ACE) Inhibitors, Angiotensin-receptor Blockers, Analgesics, and Thrombolytics), By Route of Administration (Oral and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global myocardial infarction (MI) market is estimated to exhibit a CAGR of 6.4% from 2024 to 2029. Read More »
May 6 : 2024

Global Facial Erythema Treatment Market Size, Trends & Analysis - Forecasts to 2029 By Drug Type (Emollients, Antihistamines, Antifungal, Antibiotics, Corticosteroids, and Calcineurin Inhibitors), By Route of Administration (Topical and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global facial erythema treatment market is estimated to exhibit a CAGR of 5.3% from 2024 to 2029. Read More »
May 3 : 2024

Global Anti-polyomavirus Drugs Market Size, Trends & Analysis - Forecasts to 2029 By Application (Polyomavirus-associated Nephropathy, Progressive Multifocal Leukoencephalopathy (PML), Merkel Cell Carcinoma, and Others), By End User (Hospitals, Specialty Clinics, and Research Institutions), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global anti-polyomavirus drugs market is estimated to exhibit a CAGR of 7.4% from 2024 to 2029. Read More »
April 25 : 2024

Global Pharmaceutical B2B Marketplace Market Size, Trends & Analysis - Forecasts to 2029 By Marketplace (Vertical B2B Marketplaces and Horizontal B2B Marketplaces), By Mode of Transaction (Open Marketplace and Private Marketplace), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global pharmaceutical B2B marketplace market is estimated to exhibit a CAGR of 14.6% from 2024 to 2029. Read More »
April 22 : 2024

Global Pet Dental Health Market Size, Trends & Analysis - Forecasts to 2028 By Animal Type (Dogs, Cats, and Others), By Type (Oral Care Products, Medicines, Equipment, Diagnosis, and Treatment), By Application (Gum Disease, Endodontic Diseases, Dental calculus, Oral tumor, and Others) and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global pet dental health market is expected to grow at a CAGR of 6.2% from 2023 to 2028. Read More »
January 8 : 2024

Global Omics-Based Clinical Trials Market Size, Trends & Analysis - Forecasts to 2028 By Phase Type (Phase I, Phase II, Phase III, and Phase IV), By Study Design Type (Interventional Studies, Observational Studies, and Expanded Access Studies), By Indication Type (Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases, and Others), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global omics-based clinical trials market is expected to grow at a CAGR of 8.5% from 2023 to 2028. Read More »
January 2 : 2024

Global Veterinary CRO & CDMO Market Size, Trends & Analysis - Forecasts to 2028 By Animal Type (Companion Animals and Livestock Animals), By Application Type (Medicines and Medical Devices), By Service Type (Discovery, Development, Manufacturing, Packaging & Labelling, and Market Approval & Post-marketing), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global veterinary CRO & CDMO market is expected to grow at a CAGR of 9.1% from 2023 to 2028. Read More »
January 2 : 2024